Cargando…

Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims Data

PURPOSE: Real-world evidence on the impact of forced expiratory volume in one second (FEV(1)) and exacerbations on health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD) is sparse especially with regard to GOLD ABCD groups. This study investigates how ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stöber, Alisa, Lutter, Johanna I, Schwarzkopf, Larissa, Kirsch, Florian, Schramm, Anja, Vogelmeier, Claus F, Leidl, Reiner
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473986/ https://www.ncbi.nlm.nih.gov/pubmed/34588773 http://dx.doi.org/10.2147/COPD.S313711

Ejemplares similares

Does uptake of specialty care affect HRQoL development in COPD patients beneficially? A difference-in-difference analysis linking claims and survey data
por: Stöber, Alisa, et al.
Publicado: (2023)

The relationship between body mass index and health-related quality of life in COPD: real-world evidence based on claims and survey data
por: Huber, Manuel B., et al.
Publicado: (2020)

Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study
por: Kirsch, Florian, et al.
Publicado: (2019)

Long-term weight gain in obese COPD patients participating in a disease management program: a risk factor for reduced health-related quality of life
por: Huber, Manuel B., et al.
Publicado: (2021)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

Are community-living and institutionalized dementia patients cared for differently? Evidence on service utilization and costs of care from German insurance claims data
por: Schwarzkopf, Larissa, et al.
Publicado: (2013)

Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review
por: Huber, Manuel B., et al.
Publicado: (2015)

Health-related quality of life associates with change in FEV(1) in COPD: results from the COSYCONET cohort
por: Lutter, Johanna I., et al.
Publicado: (2020)

In ‘real world’ patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations
por: Worth, Heinrich, et al.
Publicado: (2023)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019)

Patients with coronary artery disease after acute myocardial infarction: effects of continuous enrollment in a structured Disease Management Program on adherence to guideline-recommended medication, health care expenditures, and survival
por: Kirsch, Florian, et al.
Publicado: (2020)

Excess costs of dementia disorders and the role of age and gender - an analysis of German health and long-term care insurance claims data
por: Schwarzkopf, Larissa, et al.
Publicado: (2012)

Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial
por: Beeh, Kai M, et al.
Publicado: (2013)

Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD(®)
por: Vogelmeier, Claus F., et al.
Publicado: (2015)

Evaluation of exacerbations and blood eosinophils in UK and US COPD populations
por: Vogelmeier, Claus F., et al.
Publicado: (2019)

COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany
por: Vogelmeier, Claus F, et al.
Publicado: (2021)

Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
por: Karl, Florian M., et al.
Publicado: (2017)

The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort
por: Wacker, Margarethe E, et al.
Publicado: (2017)

COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study
por: Kardos, Peter, et al.
Publicado: (2020)

Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET
por: Byng, Danalyn, et al.
Publicado: (2019)

IgE is associated with exacerbations and lung function decline in COPD
por: Lommatzsch, Marek, et al.
Publicado: (2022)

Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review
por: Huber, Manuel B., et al.
Publicado: (2015)

Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities
por: Wacker, Margarethe E., et al.
Publicado: (2016)

Cardiovascular predictors of mortality and exacerbations in patients with COPD
por: Alter, Peter, et al.
Publicado: (2022)

Early Clinically Important Improvement (ECII) and Exacerbation Outcomes in COPD Patients
por: Kostikas, Konstantinos, et al.
Publicado: (2020)

Transcriptional analysis identifies potential biomarkers and molecular regulators in pneumonia and COPD exacerbation
por: Bertrams, Wilhelm, et al.
Publicado: (2020)

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
por: Vogelmeier, Claus F, et al.
Publicado: (2018)

Systemic steroids in COPD-the beauty and the beast
por: Vogelmeier, Claus F
Publicado: (2014)

Study design considerations in a large COPD trial comparing effects of tiotropium with salmeterol on exacerbations
por: Beeh, Kai-Michael, et al.
Publicado: (2009)

Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial
por: Watz, Henrik, et al.
Publicado: (2018)

Altered protease and antiprotease balance during a COPD exacerbation contributes to mucus obstruction
por: Chillappagari, Shashi, et al.
Publicado: (2015)

Novel protein biomarkers for pneumonia and acute exacerbations in COPD: a pilot study
por: Jung, Anna Lena, et al.
Publicado: (2023)

Official statistics and claims data records indicate non-response and recall bias within survey-based estimates of health care utilization in the older population
por: Hunger, Matthias, et al.
Publicado: (2013)

Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group, multicentre study
por: Ställberg, Björn, et al.
Publicado: (2009)

Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD ‘real world’ study
por: Vogelmeier, Claus F., et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET
por: Kahnert, Kathrin, et al.
Publicado: (2021)

High eosinophil blood counts are associated with a shorter length of hospital stay in exacerbated COPD patients – a retrospective analysis
por: Greulich, Timm, et al.
Publicado: (2020)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

COPD & COVID-19
por: Halpin, David M.G., et al.
Publicado: (2021)

A claims data-based comparison of comorbidity in individuals with and without dementia
por: Bauer, Kathrin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0terlk5lnqf8sfl1fmlaeeinof